Adrenal oligometastasis cured with stereotactic ablative radiotherapy
Stereotactic ablative radiotherapy (SABR) has emerged as an effective, noninvasive alternative to surgery in patients with oligometastatic disease. Historically, select patients with adrenal oligometastases have been treated with adrenalectomies which can offer durable local control and reasonable s...
Main Authors: | Julia Malone, BSC, Jason R. Pantarotto, MD FRCPC, David Tiberi, MD FRCPC, Shawn Malone, MD FRCPC |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-11-01
|
Series: | Radiology Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1930043320304489 |
Similar Items
-
Incorporating Stereotactic Ablative Radiotherapy into the Multidisciplinary Management of Renal Cell Carcinoma
by: Rohit K. Raj, et al.
Published: (2023-12-01) -
Stereotactic magnetic resonance-guided online adaptive radiotherapy of adrenal metastases combines high ablative doses with optimized sparing of organs at risk
by: Philipp Hoegen, et al.
Published: (2023-03-01) -
Stereotactic Radiotherapy for Oligometastasis
by: Sotaro Otake, et al.
Published: (2019-01-01) -
First UK patient cohort treated with stereotactic ablative radiotherapy for primary kidney cancer
by: Anjali Zarkar, et al.
Published: (2023-07-01) -
Developments in Stereotactic Body Radiotherapy
by: Anoop Haridass
Published: (2018-12-01)